1 / 14

Treatment of Chronic Non-Cancer Pain

Treatment of Chronic Non-Cancer Pain. Ross Bryan Mercer University MS III August 2012. INTRODUCTION. Chronic Non-Cancer Pain Pain lasting longer than 3 months or beyond the expected period of healing of tissue pathology Development

joelle-wall
Download Presentation

Treatment of Chronic Non-Cancer Pain

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Treatment of Chronic Non-Cancer Pain Ross Bryan Mercer University MS III August 2012

  2. INTRODUCTION • Chronic Non-Cancer Pain • Pain lasting longer than 3 months or beyond the expected period of healing of tissue pathology • Development • Develops as a result of persistent stimulation of or changes to nociceptors following injury. • Treatment Options • Pharmacological • Interventional • Psychological

  3. Pharmacological

  4. OPIOIDS(hydrocodone, tramadol) • Mechanism • Bind MOR in brain and SC • Indication • Neuropathy • Efficacy • Less pain, less function • Adverse Effects • Hyperalgesia; Abuse • Nausea, constipation, somnolence • SS (with tramadol)

  5. NSAIDs • Mechanism • Inhibits COX-1 and/or COX-2 • Indications • OA; RA; back pain • Efficacy • Not for neuropathy or FM • Adverse Effects • Gastrointestinal for COX-1 • Cardiovascular for selective COX-2

  6. TCAs and SNRIs(amytriptyline and duloxetine) • Mechanism • Increase 5-HT and NE @ Synapse • Indications • Neuropathy, fibromyalgia, low-back pain, and headaches. • Adverse Effects • TCAs --> cardiovascular events

  7. Anticonvulsants(gabapentin and carbamazepine) • Mechanism • Enhance GABA inhibitory system • Indication • Neuropathic pain • Adverse Effects • Somnolence, fatigue • Dizziness

  8. Topical Agents(Capsaicin) • Mechanism • Depletes substance P from primary afferent neurons • Indications • Neuropathy and OA • Adverse Effects • Limited

  9. Corticosteroids • Mechanism • Blocks PLA2 and IL-2 • Indications • Rediculopathy • Facet joint pain • Adverse Effects • Infection • Paraplegia

  10. Surgery • Lumbar Fusion • Non-radicular degenerative changes • Discectomy • Radiculopathy w/herniated disc • Decompressive Laminectomy • Spinal stenosis *many are associated with worsened quality of life after 4-5 years.

  11. Intrathecal Implants(morphine) • Mechanism • MOR agonists • Indications • Chronic refractory pain • Adverse Effects • Tolerance

  12. Interdisciplinary Pain Reduction Programs (IPRPs) • GOALS: • Physical therapy • Exercise • Cognitive restructuring • Drug management

  13. Comments • Data on efficacy is limited by: • Subjective outcomes • Inconsistent diagnostic criteria • Even the most effective treatments averaged a 30% reduction of pain in only half of the patients • Even with pain reduction, there is often not concomitant improvement in emotional and physical functioning

  14. Citation • Turk, Dennis, PhD, Wilson, Hilary. Treatment of Chronic Non-cancer Pain. The Lancet, 2011 vol 377: 2226-2235.

More Related